Tepmetko 225mg Tablet
Marketer
Merck Ltd
Salt Composition
Tepotinib (225mg)
Overview Tepmetko 225mg Tablet
For adult patients with advanced non-small cell lung cancer that has metastasized or is surgically inoperable and unresponsive to prior therapies, Tepmetko 225mg tablets offer a treatment option. This medication works by inhibiting tumor growth. Ingest Tepmetko 225mg tablets whole with food; do not crush or chew. Treatment duration and dosage are individualized based on patient response and condition; continue taking the medication as directed by your physician. While benefits may take weeks or months to manifest, discontinue use only upon medical advisement. Common side effects include peripheral swelling, nausea, low albumin levels, diarrhea, and elevated creatinine. Report any concerning side effects to your doctor, who may also recommend regular liver function tests. Inform your physician of all other medications you are taking, as interactions are possible. Tepmetko 225mg tablets are contraindicated during pregnancy and breastfeeding; therefore, effective contraception is crucial for both men and women of reproductive age undergoing treatment.
Primary Ingredients of Tepmetko 225mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Tepmetko 225mg Tablet
Managing Non-small Cell Lung Carcinoma
Major Benefits of Tepmetko 225mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 225mg Tepmetko tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
Common Side effects of Tepmetko 225mg Tablet:
- Peripheral edema
- Nausea
- Low albumin level in blood
- Diarrhea
- Increased creatinine level in blood
How to use Tepmetko 225mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 225mg Tepmetko tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
How Tepmetko 225mg Tablet works:
Tepmetko 225mg tablets inhibit the activity of specific aberrant proteins responsible for signaling cancerous cell proliferation, thus retarding or halting tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Tepmetko 225mg Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyUNSAFE
Use of Tepmetko 225mg tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in both animals and pregnant humans reveals substantial risks to the fetus.
Breast feedingCAUTION
The use of Tepmetko 225mg tablets while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding for the duration of their treatment and until the medication is fully cleared from their system.
DrivingSAFE
Driving ability is typically unaffected by Tepmetko 225mg tablets.
KidneySAFE IF PRESCRIBED
Patients with kidney impairment can safely use Tepmetko 225mg tablets without requiring any dosage modification.
LiverSAFE IF PRESCRIBED
Patients with liver disease can safely use Tepmetko 225mg tablets without requiring any dosage modification.
What if you forget to take Tepmetko 225mg Tablet :
Should you forget a Tepmetko 225mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tepmetko 225mg Tablet
| Label | Value |
|---|---|
| Chemical Category | P450 Enzyme Inhibitors |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently